Santarus Inc. (SNTS) and VeroScience Announce CYCLOSET (bromocriptine mesylate) Data Presentations at the American Diabetes Association Meeting
6/21/2013 7:00:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Santarus, Inc. (NASDAQ: SNTS) and VeroScience, LLC today announced that clinical data on CYCLOSET® (bromocriptine mesylate) will be featured in two poster presentations at the 73rd Scientific Sessions of the American Diabetes Association being held at McCormick Place in Chicago, Ill. from June 21 – 25, 2013.
Help employers find you! Check out all the jobs and post your resume.